 |
|
Unique role for blood formation gene identified
September 13, 2007Dartmouth Medical School research reveals new pathway for stem cell turnover
Hanover, NH--All blood cell production in adults depends on the steady work of a vital gene that if lost results in early bone marrow failure, Dartmouth Medical School cancer geneticists have found. Their research reveals an unexpected role for the gene in sustaining the adult blood-forming system, and opens novel strategies for targeting the gene, which is often involved in a type of childhood leukemia.
"We have identified a new pathway that is essential for blood stem cell turnover," said team leader Dr. Patricia Ernst, assistant professor of genetics and member of the Norris Cotton Cancer Center. The pathway could be exploited for treating a rare but aggressive infant leukemia, she added. These findings were reported in the September issue of Cell Stem Cell.
The investigators created a mouse model to track the function of a gene called MLL, which stands for Mixed Lineage Leukemia. The gene acts in bone marrow stem cells and controls key aspects of their growth to generate all the mature blood cells. If disrupted, it cannot work properly, and leukemia can ensue.
"MLL is the most commonly affected gene in childhood leukemia in children under a year of age; this particular type of leukemia has one of the worst success rates with the existing cancer therapies," said Ernst, who first helped clarify the role of MLL as a postdoctoral fellow at Harvard.
Many childhood leukemias result from mutations called translocations, where gene pieces on chromosomes accidentally relocate and misalign. In infant leukemia, the chromosome containing the MLL gene breaks within MLL and ends up fused to a different gene. MLL fusion genes likely co-opt normal MLL functions in blood cells, leading to the overproduction of white cells and leukemia.
Previous studies indicated that MLL is critical for embryonic blood stem cell development, but its role for the adult system was unknown. In their mouse model, the researchers found that bone marrow failure occurred as early as 14 days after they induced the experimental loss of MLL, demonstrating the crucial role of MLL as "necessary for both the development and maintenance of the body's blood supply," according to the researchers.
"We have shown that the adult blood-forming system depends on the continuous actions of MLL," Ernst said. Moreover, with the mouse model the scientists established to define normal MLL functions, they can begin exploring how to craft new anti-cancer treatments, she pointed out. "We and other groups can start designing targeted therapies that inhibit cancerous forms of MLL that occur in childhood leukemia and do not affect normal MLL function, which, based on our studies in mice, would be fatal for the patient."
Dartmouth Medical School
The investigators created a mouse model to track the function of a gene called MLL, which stands for Mixed Lineage Leukemia. The gene acts in bone marrow stem cells and controls key aspects of their growth to generate all the mature blood cells. If disrupted, it cannot work properly, and leukemia can ensue.
"MLL is the most commonly affected gene in childhood leukemia in children under a year of age; this particular type of leukemia has one of the worst success rates with the existing cancer therapies," said Ernst, who first helped clarify the role of MLL as a postdoctoral fellow at Harvard.
Many childhood leukemias result from mutations called translocations, where gene pieces on chromosomes accidentally relocate and misalign. In infant leukemia, the chromosome containing the MLL gene breaks within MLL and ends up fused to a different gene. MLL fusion genes likely co-opt normal MLL functions in blood cells, leading to the overproduction of white cells and leukemia.
Previous studies indicated that MLL is critical for embryonic blood stem cell development, but its role for the adult system was unknown. In their mouse model, the researchers found that bone marrow failure occurred as early as 14 days after they induced the experimental loss of MLL, demonstrating the crucial role of MLL as "necessary for both the development and maintenance of the body's blood supply," according to the researchers.
"We have shown that the adult blood-forming system depends on the continuous actions of MLL," Ernst said. Moreover, with the mouse model the scientists established to define normal MLL functions, they can begin exploring how to craft new anti-cancer treatments, she pointed out. "We and other groups can start designing targeted therapies that inhibit cancerous forms of MLL that occur in childhood leukemia and do not affect normal MLL function, which, based on our studies in mice, would be fatal for the patient."
Dartmouth Medical School
Leukemia News and Current Leukemia Events RSSNew insights into the regulation of PTEN tumor suppression function
The PTEN tumor suppressor gene controls numerous biological processes including cell proliferation, cell growth and death. But PTEN is frequently lost or mutated; in fact, alteration of the gene is so common among various types of human cancer that PTEN has become one of the most frequently mutated of all tumor suppressors.
Children's national co-leads nationwide study of landmark sickle cell treatment
Children's National Medical Center immunologist and blood and marrow transplant physician Naynesh Kamani, MD, will serve as the study co-chair for a new national clinical trial of unrelated donor marrow and umbilical cord blood transplants for severe sickle cell disease.
Newly discovered molecular switch helps decide cell type in early embryo development
Researchers have discovered a central molecular switch in fruit fly embryos that opens new avenues for studying the causes of birth defects and cancer in humans. Writing about their study in the Aug. 12 Developmental Cell, scientists at Cincinnati Children's Hospital Medical Center determined the switch to be a main tuning mechanism for instructing cells whether to form sensory nerves or blood cells in different parts of the body.
McGill researchers overcome chemotherapy resistance in the lab
Researchers from McGill University's Faculty of Medicine have discovered a compound that reduces resistance to chemotherapy agents used to treat cancer. Their results were published in the June issue of The Journal of Clinical Investigation (JCI).
Crucial Factors in Lymphoma Development and Survival Discovered
Researchers at National Jewish Medical and Research Center have discovered an important factor in the development of B-cell lymphomas, one of the fastest growing forms of cancer.
Leukemia drug could save lives of stroke patients
The drug tPA is the most effective treatment currently available for stroke patients, but its safety is limited to use within the first three hours following the onset of symptoms.
Stroke study reveals key target for improving treatment and suggests that Gleevec may help
For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.
Math could help cure leukemia
When kids complain that math homework won't help them in real life, a new answer might be that math could help cure cancer.
Combining math and medicine to treat leukemia
Researchers have produced a mathematical model that may lead to the development of an optimally-timed vaccine for chronic myelogenous leukemia (CML).
Gene mutation improves leukemia drug's effect
Gene mutations that make cells cancerous can sometimes also make them more sensitive to chemotherapy. A new study led by cancer researchers at Ohio State University shows that a mutation present in some cases of acute leukemia makes the disease more susceptible to high doses of a particular anticancer drug.
More Leukemia News Articles
 | My Sister's Keeper: A Novel by Jodi Picoult New York Times bestselling author Jodi Picoult is widely acclaimed for her keen insights into the hearts and minds of real people. Now she tells the emotionally riveting story of a family torn apart by conflicting needs and a passionate love that triumphs over human weakness.Anna is not sick, but she might as well be. By age thirteen, she has undergone countless surgeries, transfusions, and shots... |
 | Drums, Girls, And Dangerous Pie by Jordan Sonnenblick Thirteen-year-old Steven has a totally normal life: he plays drums in the All-Star Jazz band, has a crush on the hottest girl in the school, and is constantly annoyed by his five-year-old brother, Jeffrey. But when Jeffrey is diagnosed with leukemia, Steven's world is turned upside down. He is forced to deal with his brother's illness and his parents' attempts to keep the family in one piece.... |
 | Sadako and the Thousand Paper Cranes (PMC) (Puffin Modern Classics) by Eleanor Coerr Born in Hiroshima in 1943, Sadako was the star of her school’s running team, until the dizzy spells started and she was forced to face the hardest race of her life—the race against... |
 | It's Only Temporary: The Good News and the Bad News of Being Alive by Evan Handler A provocative, funny, and whip- smart memoir of how one man learned to find joy in his own life after years of hand-to-hand combat with death. Actor and author Evan Handler’s new book, It’s Only Temporary, is both a deeply personal memoir and a series of meditations on life, love, faith, gratitude, and mortality. In closely examining his own triumphs, mistakes, and less-than-ideal relationships... |
 | The Breuss Cancer Cure: Advice for the Prevention and Natural Treatment of Cancer, Leukemia and Other Seemingly Incurable Diseases by Rudolf Breuss |
 | Gideon's Gift (The Red Gloves Collection #1) by Karen Kingsbury One long-ago Christmas, Big Earl Gibson lost the two things most precious to him-his wife and daughter. Angry and heartbroken, he abandoned his belief in God and is now living on the street. Gideon is a seven-year-old leukemia patient determined to reach out to this lonely and hurting man. And Earl is just as determined to rebuff her. It is only through a miracle that Earl finally comes to... |
 | The Rainmaker by John Grisham Michael Beck (The Golden Seal, Xanadu), who seems to be making a career out of reading books on audio (A Time to Kill, The Runaway Jury), has returned with John Grisham's The Rainmaker, bringing the backwoods of Tennessee's legal world to life. His sultry, southern drawl animates the world of Rudy Baylor, an out-of-luck, budding lawyer who has more things going against him than bedraggled, ... |
 | It's Good to Know a Miracle: Dani's Story: One Family's Struggle with Leukemia by Jay Shotel, Sue Shotel Distributed by the University of Nebraska Press for Richard Altschuler & Associates, Inc./ Gordian Knot Books In August 2002 Dani Shotel was a healthy twenty-six-year-old young woman with an almost perfect life. She had a gratifying job as a special-needs teacher in an elementary school, many friends, a loving family, and a fiancé, Scott Greene, whom she was soon to marry. One month later she was... |
 | Sadako by Eleanor Coerr |
 | 100 Questions & Answers About Lymphoma by Peter Holman, Jodi Garrett, William D. Jansen This book deals with lymphoma from a doctor's and a caregiver's... |
| © 2008 BrightSurf.com |